374.34  -2.285 (-0.61%)		04-30 10:44
Open: 373.5 High: 374.67 Volume: 263,819		Pre. Close: 376.625 Low: 365.2 Market Cap: 81,293(M)

Short term
Mid term
Targets	6-month :	440.06	1-year :	513.99
Resists	First :	376.76	Second :	440.06
Pivot price	335.03
Supports	First :	318.48	Second :	282.45
MAs	MA(5) :	362.5	MA(20) :	328.78
	MA(100) :	330.13	MA(250) :	332.3
MACD	MACD :	16.4	Signal :	10.5
%K %D	K(14,3) :	95.6	D(3) :	95
RSI	RSI(14): 77.1
52-week	High :	415.37	Low :	269.16

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
[ ELV ] has closed below upper band by 8.0%. Bollinger Bands are 94.9% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 2 days. This is a sign that the current trend might continue.

If tomorrow:	Open lower	Open higher
High:	377.22 - 378.67	378.67 - 380.12
Low:	361.4 - 363.14	363.14 - 364.87
Close:	373.79 - 376.49	376.49 - 379.18

Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health Inc. in June 2022. Elevance Health Inc. was founded in 1944 and is headquartered in Indianapolis, Indiana.

Thu, 30 Apr 2026
Healthcare costs rose 26% for small firms; Elevance offers fixed payments - Stock Titan

Wed, 29 Apr 2026
Elevance Health hikes guidance after Q1 beat, citing cost control - MSN

Wed, 29 Apr 2026
Vanguard Capital Management increases stake in Elevance Health (NYSE: ELV) — 16.6M shares - Stock Titan

Tue, 28 Apr 2026
symbol__ Stock Quote Price and Forecast - CNN

Tue, 28 Apr 2026
Elevance Health (ELV) Positioned for Long-Term Margin Improvement Amid Medium-Term Challenges - Insider Monkey

Tue, 28 Apr 2026
Elevance Health (ELV) Positioned for Long-Term Margin Improvement Amid Medium-Term Challenges - Yahoo Finance

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Outperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Neutral
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Outperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Outperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Outperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Underperform

Exchange: NYSE
Sector: Healthcare
Industry: Medical - Healthcare Plans
Shares Out	220 (M)
Shares Float	220 (M)
Held by Insiders	0.1 (%)
Held by Institutions	94.3 (%)
Shares Short	3,970 (K)
Shares Short P.Month	4,230 (K)

EPS	25.2
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	198.8
Profit Margin	2.8 %
Operating Margin	1.5 %
Return on Assets (ttm)	4.3 %
Return on Equity (ttm)	13.2 %
Qtrly Rev. Growth	9.5 %
Gross Profit (p.s.)	231.72
Sales Per Share	906.53
EBITDA (p.s.)	41.15
Qtrly Earnings Growth	36.2 %
Operating Cash Flow	4,290 (M)
Levered Free Cash Flow	3,400 (M)

PE Ratio	14.77
PEG Ratio	1.2
Price to Book value	1.87
Price to Sales	0.41
Price to Cash Flow	19.06

Dividend	1.72
Forward Dividend	0
Dividend Yield	0.4%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.